Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Haemonetics (HAE) Receivables - Other (2017 - 2022)

Haemonetics has reported Receivables - Other over the past 7 years, most recently at $6.6 million for Q4 2022.

  • Quarterly results put Receivables - Other at $6.6 million for Q4 2022, up 20.0% from a year ago — trailing twelve months through Dec 2022 was $6.6 million (up 20.0% YoY), and the annual figure for FY2022 was $5.5 million, up 14.58%.
  • Receivables - Other for Q4 2022 was $6.6 million at Haemonetics, down from $7.6 million in the prior quarter.
  • Over the last five years, Receivables - Other for HAE hit a ceiling of $10.5 million in Q4 2018 and a floor of $2.1 million in Q1 2018.
  • Median Receivables - Other over the past 5 years was $5.6 million (2019), compared with a mean of $6.0 million.
  • Biggest five-year swings in Receivables - Other: skyrocketed 166.67% in 2019 and later tumbled 34.33% in 2021.
  • Haemonetics' Receivables - Other stood at $10.5 million in 2018, then fell by 23.81% to $8.0 million in 2019, then tumbled by 32.5% to $5.4 million in 2020, then decreased by 18.52% to $4.4 million in 2021, then soared by 50.0% to $6.6 million in 2022.
  • The last three reported values for Receivables - Other were $6.6 million (Q4 2022), $7.6 million (Q4 2022), and $6.4 million (Q3 2022) per Business Quant data.